Abstract Early identification of infants at risk of atopic dermatitis (AD) is critical for timely prevention, yet preclinical biomarkers remain elusive. In this nested study within the prospective Singapore Preconception Study of Long-Term Maternal and Child Outcomes (S-PRESTO) cohort (ClinicalTrials.gov NCT03531658), we investigated whether early molecular signatures of infant skin could predict disease onset.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile